Buy, Hold or Sell ISRG Stock Now?
Intuitive Surgical, Inc. ISRG is set to report third-quarter 2025 earnings on Oct. 21. The Zacks Consensus Estimate for sales and earnings is pegged at $2.41 billion and $1.99 per share, respectively. Earnings per share estimates for ISRG have remained stable at $8.16 and $9.17 for 2025 and 2026, respectively, over the past 30 days. The company expects worldwide da Vinci procedures to increase approximately 15.5-17% in 2025, a trend that should have benefited the top line in the to-be-reported quarter.
Intuitive Surgical’s close peers, Thermo Fisher Scientific TMO andBoston ScientificBSX, are slated to announce their quarterly numbers in the upcoming week. (Stay up-to-date with all quarterly releases: See Zacks Earnings…
